Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Healthcare Resource Consumption and Related Costs in Patients on Antiretroviral Therapies: Findings from Real-World Data in Italy.
Perrone V, Dovizio M, Sangiorgi D, Andretta M, Bartolini F, Cavaliere A, Ciaccia A, Chinellato A, Costantini A, Dell'Orco S, Ferrante F, Gentile S, Lavalle A, Moscogiuri R, Mosele E, Procacci C, Re D, Santoleri F, Roccia A, Maggiolo F, Degli Esposti L. Perrone V, et al. Among authors: chinellato a. Int J Environ Res Public Health. 2023 Feb 21;20(5):3789. doi: 10.3390/ijerph20053789. Int J Environ Res Public Health. 2023. PMID: 36900813 Free PMC article.
Analysis of Patients with Focal Epilepsy and Drug-Resistant Epilepsy in Italy: Evaluation of Their Characteristics, Therapeutic Pathway and the Consumption of Healthcare Resources.
Perrone V, Veronesi C, Dovizio M, Ancona DD, Andretta M, Bartolini F, Cavaliere A, Chinellato A, Ciaccia A, Cillo M, De Francesco A, Enieri N, Ferrante F, Gentile S, Procacci C, Ubertazzo L, Vercellone A, Lucatelli D, Procaccini M, Degli Esposti L. Perrone V, et al. Among authors: chinellato a. Clinicoecon Outcomes Res. 2022 Jul 28;14:513-521. doi: 10.2147/CEOR.S361692. eCollection 2022. Clinicoecon Outcomes Res. 2022. PMID: 35923519 Free PMC article.
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents?
Ingrasciotta Y, Sultana J, Formica D, Ientile V, Aiello A, Chinellato A, Tari DU, Gini R, Pastorello M, Scondotto S, Cananzi P, Traversa G, Rossi M, Santoro D, Trifirò G; Italian Biosimilars Network (I-BioNetwork). Ingrasciotta Y, et al. Among authors: chinellato a. Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):65-77. doi: 10.1002/pds.5152. Epub 2020 Nov 16. Pharmacoepidemiol Drug Saf. 2021. PMID: 33067914
Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.
Rischio and Prevenzione Investigators. Rischio and Prevenzione Investigators. Trials. 2010 May 28;11:68. doi: 10.1186/1745-6215-11-68. Trials. 2010. PMID: 20509875 Free PMC article. Clinical Trial.
NSAIDs utilization for musculoskeletal indications in elderly patients with cerebro/cardiovascular disease.
Roberto G, Bartolini C, Rea F, Onder G, Vitale C, Trifirò G, Kirchmayer U, Chinellato A, Lucenteforte E, Corrao G, Mugelli A, Lapi F, Gini R; Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE). Roberto G, et al. Among authors: chinellato a. Eur J Clin Pharmacol. 2018 May;74(5):637-643. doi: 10.1007/s00228-018-2411-y. Epub 2018 Jan 30. Eur J Clin Pharmacol. 2018. PMID: 29383397 Free PMC article.
82 results